platoseed
← All companies
Synkrino Biotherapeutics logo

Synkrino Biotherapeutics

Active

Synkrino's AI, SATIS is a powerful, unbiased discovery system for…

Summer 20182 peopleOakland, CA, USA
Generate ideas →
↻ Pivot / rename signal

This company has previously operated under SF17 Therapeutics. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.

Founders · 2

Jason Barbour
Jason BarbourFounder/CEO
David Ott
David OttFounder/CTO
HealthcareDrug Discovery and DeliveryAI-powered Drug DiscoveryBiotech

Related startups

Also in Summer 2018